Mirikizumab-mrkz Injection — FDA Drug Shortage

To Be Discontinued — Eli Lilly And Co.

The FDA lists a drug shortage record for Mirikizumab-mrkz Injection (injection) from Eli Lilly And Co. with status To Be Discontinued. The shortage was first posted on Dec 22, 2025.

Shortage details

Status
To Be Discontinued
Company
Eli Lilly And Co.
Package NDC
0002-8870-27
Dosage Form
Injection
Presentation
Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)
Initial Posting
Dec 22, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.